Letter to the editor regarding "Cost-effectiveness of benralizumab versus mepolizumab and dupilumab in patients with severe uncontrolled eosinophilic asthma in Spain".

Subjects

Subjects :

*ASTHMATICS
*STOCK options
*QUALITY-adjusted life years
*TIME perspective
*MEDICAL writing

Details

Language :

English

ISSN :

02770903

Volume :

62

Issue :

2

Database :

Academic Search Index

Journal :

Journal of Asthma

Publication Type :

Academic Journal

Accession number :

182410933

Full Text :

https://doi.org/10.1080/02770903.2024.2394145